{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:56:16Z","timestamp":1790045776243,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7379\u2013 iTIRONET-CM"],"award-info":[{"award-number":["P2022\/BMD-7379\u2013 iTIRONET-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7379\u2013 iTIRONET-CM"],"award-info":[{"award-number":["P2022\/BMD-7379\u2013 iTIRONET-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7379\u2013 iTIRONET-CM"],"award-info":[{"award-number":["P2022\/BMD-7379\u2013 iTIRONET-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7379\u2013 iTIRONET-CM"],"award-info":[{"award-number":["P2022\/BMD-7379\u2013 iTIRONET-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7379\u2013 iTIRONET-CM"],"award-info":[{"award-number":["P2022\/BMD-7379\u2013 iTIRONET-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012818","name":"Comunidad de Madrid","doi-asserted-by":"publisher","award":["P2022\/BMD-7379\u2013 iTIRONET-CM"],"award-info":[{"award-number":["P2022\/BMD-7379\u2013 iTIRONET-CM"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["CLSEN258522VALD"],"award-info":[{"award-number":["CLSEN258522VALD"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","award":["CLSEN258522VALD"],"award-info":[{"award-number":["CLSEN258522VALD"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04717-1","type":"journal-article","created":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T10:57:12Z","timestamp":1786186632000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Determinants of physicians\u2019 risk-benefit perceptions of adjuvant radioactive iodine for differentiated thyroid cancer"],"prefix":"10.1007","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2529-1502","authenticated-orcid":false,"given":"Carlos","family":"Garcia-Regal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6061-9751","authenticated-orcid":false,"given":"Jhonatan","family":"Qui\u00f1ones-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3218-2550","authenticated-orcid":false,"given":"Alberto","family":"Martinez-Lorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1097-1436","authenticated-orcid":false,"given":"Noemi","family":"Brox-Torrecilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0034-7808","authenticated-orcid":false,"given":"Sandra","family":"Campos Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8966-7236","authenticated-orcid":false,"given":"Teresa","family":"Alonso-Gordoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9562-8276","authenticated-orcid":false,"given":"Joaqu\u00edn","family":"G\u00f3mez-Ram\u00edrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8379-2709","authenticated-orcid":false,"given":"Pablo","family":"Valderrabano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,8]]},"reference":[{"key":"4717_CR1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4274\/mirt.galenos.2020.83703","volume":"29","author":"JD Ehrhardt Jr","year":"2020","unstructured":"J.D. Jr Ehrhardt, S. G\u00fcle\u00e7, A Review of the History of Radioactive Iodine Theranostics: The Origin of Nuclear Ontology. Mirt. 29, 88\u201397 (2020). https:\/\/doi.org\/10.4274\/mirt.galenos.2020.83703","journal-title":"Mirt"},{"key":"4717_CR2","unstructured":"A.M. Avram, F.A. Verburg, A.S.N.M.M.I. Vrachimis, Procedure Standard\/EANM Practice Guideline for Nuclear Medicine Evaluation and Therapy of Differentiated Thyroid Cancer: Abbreviated Version"},{"key":"4717_CR3","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/10507256251363120","volume":"35","author":"MD Ringel","year":"2025","unstructured":"M.D. Ringel, J.A. Sosa, Z. Baloch et al., 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer. Thyroid\u00ae. 35, 841\u2013985 (2025). https:\/\/doi.org\/10.1177\/10507256251363120","journal-title":"Thyroid\u00ae"},{"key":"4717_CR4","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"RM Tuttle","year":"2019","unstructured":"R.M. Tuttle, S. Ahuja, A.M. Avram et al., Controversies, Consensus, and Collaboration in the Use of131 I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 29, 461\u2013470 (2019). https:\/\/doi.org\/10.1089\/thy.2018.0597","journal-title":"Thyroid"},{"key":"4717_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"B.R. Haugen, E.K. Alexander, K.C. Bible et al., 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 26, 1\u2013133 (2016). https:\/\/doi.org\/10.1089\/thy.2015.0020","journal-title":"Thyroid"},{"key":"4717_CR6","doi-asserted-by":"crossref","unstructured":"M.D. Ringel, J.A. Sosa, Z. Baloch et al., 2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer","DOI":"10.1177\/10507256251363120"},{"key":"4717_CR7","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"P.A. Harris, R. Taylor, B.L. Minor et al., The REDCap consortium: Building an international community of software platform partners. J. Biomed. Inform. 95, 103208 (2019). https:\/\/doi.org\/10.1016\/j.jbi.2019.103208","journal-title":"J. Biomed. Inform."},{"key":"4717_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"P.A. Harris, R. Taylor, R. Thielke et al., Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inform. 42, 377\u2013381 (2009). https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010","journal-title":"J. Biomed. Inform."},{"key":"4717_CR9","unstructured":"R Core Team, (2025) R: A language and environment for statistical computing"},{"key":"4717_CR10","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","volume":"366","author":"U Mallick","year":"2012","unstructured":"U. Mallick, C. Harmer, B. Yap et al., Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer. N Engl. J. Med. 366, 1674\u20131685 (2012). https:\/\/doi.org\/10.1056\/NEJMoa1109589","journal-title":"N Engl. J. Med."},{"key":"4717_CR11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","volume":"366","author":"M Schlumberger","year":"2012","unstructured":"M. Schlumberger, B. Catargi, I. Borget et al., Strategies of Radioiodine Ablation in Patients with Low-Risk Thyroid Cancer. N Engl. J. Med. 366, 1663\u20131673 (2012). https:\/\/doi.org\/10.1056\/NEJMoa1108586","journal-title":"N Engl. J. Med."},{"key":"4717_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/S2213-8587(18)30306-1","volume":"7","author":"H-M Dehbi","year":"2019","unstructured":"H.-M. Dehbi, U. Mallick, J. Wadsley et al., Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial. Lancet Diabetes Endocrinol. 7, 44\u201351 (2019). https:\/\/doi.org\/10.1016\/S2213-8587(18)30306-1","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4717_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S2213-8587(18)30113-X","volume":"6","author":"M Schlumberger","year":"2018","unstructured":"M. Schlumberger, S. Leboulleux, B. Catargi et al., Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial. Lancet Diabetes Endocrinol. 6, 618\u2013626 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(18)30113-X","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4717_CR14","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1056\/NEJMoa2111953","volume":"386","author":"S Leboulleux","year":"2022","unstructured":"S. Leboulleux, C. Bournaud, C.N. Chougnet et al., Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer. N Engl. J. Med. 386, 923\u2013932 (2022). https:\/\/doi.org\/10.1056\/NEJMoa2111953","journal-title":"N Engl. J. Med."},{"key":"4717_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S2213-8587(24)00276-6","volume":"13","author":"S Leboulleux","year":"2025","unstructured":"S. Leboulleux, C. Bournaud, C.N. Chougnet et al., Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial. Lancet Diabetes Endocrinol. 13, 38\u201346 (2025). https:\/\/doi.org\/10.1016\/S2213-8587(24)00276-6","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4717_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00259-020-04952-2","volume":"48","author":"V Wenter","year":"2021","unstructured":"V. Wenter, N.L. Albert, M. Unterrainer et al., Clinical impact of follicular oncocytic (H\u00fcrthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma. Eur. J. Nucl. Med. Mol. Imaging. 48, 449\u2013460 (2021). https:\/\/doi.org\/10.1007\/s00259-020-04952-2","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4717_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1210\/jc.2014-1634","volume":"100","author":"A-M Chindris","year":"2015","unstructured":"A.-M. Chindris, J.D. Casler, V.J. Bernet et al., Clinical and Molecular Features of H\u00fcrthle Cell Carcinoma of the Thyroid. J. Clin. Endocrinol. Metabolism. 100, 55\u201362 (2015). https:\/\/doi.org\/10.1210\/jc.2014-1634","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4717_CR18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1001\/jamaoto.2023.4323","volume":"150","author":"LA Bischoff","year":"2024","unstructured":"L.A. Bischoff, I. Ganly, L. Fugazzola et al., Molecular Alterations and Comprehensive Clinical Management of Oncocytic Thyroid Carcinoma: A Review and Multidisciplinary 2023 Update. JAMA Otolaryngol. Head Neck Surg. 150, 265 (2024). https:\/\/doi.org\/10.1001\/jamaoto.2023.4323","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"4717_CR19","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1186\/s12885-020-06915-0","volume":"20","author":"X Zhou","year":"2020","unstructured":"X. Zhou, Z. Zheng, C. Chen et al., Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study. BMC Cancer. 20, 407 (2020). https:\/\/doi.org\/10.1186\/s12885-020-06915-0","journal-title":"BMC Cancer"},{"key":"4717_CR20","doi-asserted-by":"publisher","first-page":"e2402","DOI":"10.1210\/clinem\/dgab139","volume":"106","author":"LP Wallner","year":"2021","unstructured":"L.P. Wallner, M. Banerjee, D. Reyes-Gastelum et al., Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer. J. Clin. Endocrinol. Metabolism. 106, e2402\u2013e2412 (2021). https:\/\/doi.org\/10.1210\/clinem\/dgab139","journal-title":"J. Clin. Endocrinol. Metabolism"},{"key":"4717_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1002\/cncr.27721","volume":"119","author":"MR Haymart","year":"2013","unstructured":"M.R. Haymart, M. Banerjee, D. Yang et al., The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer. Cancer. 119, 259\u2013265 (2013). https:\/\/doi.org\/10.1002\/cncr.27721","journal-title":"Cancer"},{"key":"4717_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s12020-023-03488-3","volume":"83","author":"JJ D\u00edez","year":"2023","unstructured":"J.J. D\u00edez, P. Parente, M. Dur\u00e1n-Poveda, Surgical management of low-risk papillary thyroid cancer in real life in Spain: a nationwide survey of endocrine neck surgeons and endocrinologists. Endocrine. 83, 422\u2013431 (2023). https:\/\/doi.org\/10.1007\/s12020-023-03488-3","journal-title":"Endocrine"},{"key":"4717_CR23","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1245\/s10434-021-09898-9","volume":"28","author":"AD McDow","year":"2021","unstructured":"A.D. McDow, M.C. Saucke, N.A. Marka et al., Thyroid Lobectomy for Low-Risk Papillary Thyroid Cancer: A National Survey of Low- and High-Volume Surgeons. Ann. Surg. Oncol. 28, 3568\u20133575 (2021). https:\/\/doi.org\/10.1245\/s10434-021-09898-9","journal-title":"Ann. Surg. Oncol."},{"key":"4717_CR24","doi-asserted-by":"publisher","first-page":"e228722","DOI":"10.1001\/jamanetworkopen.2022.8722","volume":"5","author":"PH Dedhia","year":"2022","unstructured":"P.H. Dedhia, M.C. Saucke, K.L. Long et al., Physician Perspectives of Overdiagnosis and Overtreatment of Low-Risk Papillary Thyroid Cancer in the US. JAMA Netw. Open. 5, e228722 (2022). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.8722","journal-title":"JAMA Netw. Open."},{"key":"4717_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1089\/thy.2019.0587","volume":"30","author":"CB Jensen","year":"2020","unstructured":"C.B. Jensen, M.C. Saucke, D.O. Francis et al., From Overdiagnosis to Overtreatment of Low-Risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients. Thyroid. 30, 696\u2013703 (2020). https:\/\/doi.org\/10.1089\/thy.2019.0587","journal-title":"Thyroid"},{"key":"4717_CR26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s12020-020-02418-x","volume":"70","author":"A Campenn\u00ec","year":"2020","unstructured":"A. Campenn\u00ec, D. Barbaro, M. Guzzo et al., Personalized management of differentiated thyroid cancer in real life \u2013 practical guidance from a multidisciplinary panel of experts. Endocrine. 70, 280\u2013291 (2020). https:\/\/doi.org\/10.1007\/s12020-020-02418-x","journal-title":"Endocrine"},{"key":"4717_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1007\/s00259-019-04557-4","volume":"47","author":"O Maas","year":"2020","unstructured":"O. Maas, F. Forrer, M. Maas et al., Variations in radioiodine ablation: decision-making after total thyroidectomy. Eur. J. Nucl. Med. Mol. Imaging. 47, 554\u2013560 (2020). https:\/\/doi.org\/10.1007\/s00259-019-04557-4","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"4717_CR28","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0140-6736(25)00629-4","volume":"406","author":"U Mallick","year":"2025","unstructured":"U. Mallick, K. Newbold, M. Beasley et al., Thyroidectomy with or without postoperative radioiodine for patients with low-risk differentiated thyroid cancer in the UK (IoN): a randomised, multicentre, non-inferiority trial. Lancet. 406, 52\u201362 (2025). https:\/\/doi.org\/10.1016\/S0140-6736(25)00629-4","journal-title":"Lancet"},{"key":"4717_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S2213-8587(24)00306-1","volume":"13","author":"FA Verburg","year":"2025","unstructured":"F.A. Verburg, De B. Keizer, One step closer to the end of postoperative radioactive iodine thyroid remnant ablation. Lancet Diabetes Endocrinol. 13, 5\u20136 (2025). https:\/\/doi.org\/10.1016\/S2213-8587(24)00306-1","journal-title":"Lancet Diabetes Endocrinol."},{"key":"4717_CR30","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1089\/thy.2021.0323","volume":"31","author":"SC Pitt","year":"2021","unstructured":"S.C. Pitt, M.C. Saucke, B.R. Roman et al., The Influence of Emotions on Treatment Decisions About Low-Risk Thyroid Cancer: A Qualitative Study. Thyroid. 31, 1800\u20131807 (2021). https:\/\/doi.org\/10.1089\/thy.2021.0323","journal-title":"Thyroid"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04717-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04717-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04717-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T10:57:18Z","timestamp":1786186638000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04717-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,8]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4717"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04717-1","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,8]]},"assertion":[{"value":"25 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Ram\u00f3n y Cajal University Hospital (No. 330\/21).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"259"}}